Home ›
Organizations ›
NATIONAL SCLERODERMA FOUNDATION
NATIONAL SCLERODERMA FOUNDATION
MA · Medical Research · EIN 521375827
7
Executives Disclosed
$6.6M
Annual Revenue
$11.3M
Total Assets
1.6:1
Internal Pay Ratio
NATIONAL SCLERODERMA FOUNDATION has 7 executives with disclosed compensation. The highest-paid executive, Mary J Wheatley (CEO), received peak total compensation of $278,003. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Mary J Wheatley | CEO | $278K | $278K | 2022–2025 | 3.7x |
| Michael B Hyde | VP OF FINANCE | $192K | $169K | 2021–2025 | 2.6x |
| Ashley M Pruett | VP OF COMMUNITY ENGAGEMENT | $170K | $170K | 2024–2025 | 2.3x |
| Robert J Riggs | CEO (UNTIL DEC 2021) | $134K | $0 | 2016–2022 | 1.8x |
| Catherine M Anastasia | SENIOR DIRECTOR, MISSION DELIVERY | $128K | $0 | 2025–2025 | 1.7x |
| Elizabeth J Mulroy | SENIOR DIRECTOR, CHAPTER OPERATIONS | $117K | $0 | 2025–2025 | 1.6x |
| Kerri Connolly | NAT. DIRECTOR OF PROGRAMS & SERV. | $116K | $0 | 2021–2021 | 1.5x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 1 | $0 | $0 | $0 |
| 2017 | 1 | $0 | $0 | $0 |
| 2018 | 1 | $0 | $0 | $0 |
| 2019 | 1 | $0 | $0 | $0 |
| 2020 | 1 | $0 | $0 | $0 |
| 2021 | 3 | $0 | $0 | $0 |
| 2022 | 3 | $159K | $159K | $159K |
| 2023 | 2 | $213K | $243K | $426K |
| 2024 | 3 | $223K | $254K | $446K |
| 2025 | 5 | $206K | $278K | $617K |
Email Alerts
Get notified about NATIONAL SCLERODERMA FOUNDATION
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.